Everand Logo

Welcome to Everand!

  • STAT

    With a surge in cases of mysterious polio-like condition, CDC appeals to doctors to help crack case

    With a surge in cases of mysterious polio-like condition, the CDC is appealing to doctors for help to help crack the case.
    by Helen Branswell Jul 09, 2019 4 minutes
    Braden Scott uses a device to support his left arm as he practices on the piano in Tomball, Texas. He was diagnosed with acute flaccid myelitis in 2016 and was paralyzed almost completely.

    The Centers for Disease Control and Prevention on Tuesday appealed to doctors to rapidly report suspected cases of a mysterious ailment that afflicts young children, saying delays in identifying possible cases of acute flaccid myelitis, or AFM, are hindering the search for the condition’s cause.

    Every two years since 2014, a surge of the polio-like illnesses has struck a number of young children across the country, leaving them with weakened limbs. Efforts to find the cause of the phenomenon have pointed to viral infections as a possible culprit, but to date no one virus has been clearly implicated.

    Dr. Tom Clark, deputy director of CDC’s division of viral diseases,

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related